Measurement of Sub Foveal Choroidal Thickness in Patients with Hypertension
DOI:
https://doi.org/10.51253/pafmj.v76i2.11964Keywords:
Blood pressure, Choroidal thickness, Systemic arterial hypertensionAbstract
Objective: To measure sub-foveal choroidal thickness variability in adolescent people with systemic arterial hypertension.
Study Design: Comparative Cross Sectional study.
Place and Duration of Study: Armed Forces Institute of Ophthalmology, Rawalpindi, Pakistan from May to Dec 2023.
Methodology: This study recruited 15 young hypertensive subjects and 15 healthy control persons. Choroidal thickness was estimated using swept source- 3D optical coherence tomography. Choroidal thickness was only checked at the sub foveal site. Mercury sphygmomanometer was used to check systolic blood pressure (SBP), diastolic blood pressure (DBP), and mean arterial pressure (MAP) was calculated. Statistical analysis between the groups was only applied on left eye values.
Results: A total of 30 individuals were included in the study, 15 in each group. The median systolic blood pressure of the Cases was 140.00 mmHg (148.00-137.00) while in Control Group was 127.00 mmHg (143.00-118.00). Similarly, the median diastolic blood of the Cases was 90.00 mmHg (94.00-87.00) and in Control Group was 84.00 mmHg (92.00-76.00). There was significant difference in the median Intraocular pressure of both the Study Groups [Cases: 105.00 mmHg (110.00-99.00) vs. Control: 96.00 mmHg (102.00-88.00); p=0.004]. The median Sub foveal Choroidal thickness of the Cases was 279.00 mmHg (288.00-269.00) and in Controls was 290.00 mm Hg (299.00-280.00).
Conclusions: The outcomes of this research showed that subfoveal choroidal thickness reduces in people with systemic arterial hypertension. This can be due to arteriolar sclerosis and narrowing due to raised vascular pressure in the choroid.
Downloads
References
1. Mirshahi A, Karkhaneh R, Roohipour R, Rajabi M, Vahedian Z, Bazvand F. Optical Coherence Tomography Angiography Findings in Malignant Hypertensive Retinopathy. J Ophthalmic Vis Res 2022; 17(3): 432-436. Erratum in: J Ophthalmic Vis Res 2022; 17(4): 608.
https://doi.org/10.18502/jovr.v17i3.11583
2. Shao L, Zhou LX, Xu L, Wei WB. The relationship between Subfoveal Choroidal Thickness and Hypertensive Retinopathy. Sci Rep 2021; 11(1): 5460.
https://doi.org/10.1038/s41598-021-84947-7
3. Wei WB, Xu L, Jonas JB, Shao L, Du KF, Wang S, et al. Subfoveal choroidal thickness: the Beijing Eye Study. Ophthalmology 2013; 120(1): 175-180.
https://doi.org/10.1016/j.ophtha.2012.07.048
4. Cömerter D, Baysal T, Doğan S, Erdem A, Çınar T. Comparison of choroidal thickness and choroidal vascular index in normotensive dippers and nondippers. Rev Assoc Med Bras 2024; 70(1): e20230950.
https://doi.org/10.1590/1806-9282.20230950
5. Mansoori T, Charan ASR, Nagalla B. Topography and Choroidal Thickness Measurement in Healthy Asian Indian Subjects using RTVue XR 100 Optical Coherence Tomography. Middle East Afr J Ophthalmol 2024; 30(1): 19-23.
https://doi.org/10.4103/meajo.meajo_89_23
6. Tsukikawa M, Stacey AW. A Review of Hypertensive Retinopathy and Chorioretinopathy. Clin Optom 2020; 12: 67-73. https://doi.org/10.2147/OPTO.S183492
7. Modi P, Arsiwalla T. Hypertensive Retinopathy. In: Stat Pearls [Internet]. Treasure Island (FL): Stat Pearls Publishing; 2024.
8. Cheung CY, Biousse V, Keane PA, Schiffrin EL, Wong TY. Hypertensive eye disease. Nat Rev Dis Primers 2022; 8(1): 14. https://doi.org/10.1038/s41572-022-00342-0
9. Padwal R, Straus SE, McAlister FA. Evidence based management of hypertension. Cardiovascular risk factors and their effects on the decision to treat hypertension: evidence based review. BMJ. 2001; 322(7292): 977-980.
https://doi.org/10.1136/bmj.322.7292.977
10. Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension 2020; 75(6): 1334-1357.
https://doi.org/10.1161/hypertensionaha.120.15026
11. Ostrin LA, Harb E, Nickla DL, Read SA, Alonso-Caneiro D, Schroedl F, et al. IMI-The Dynamic Choroid: New Insights, Challenges, and Potential Significance for Human Myopia. Invest Ophthalmol Vis Sci 2023; 64(6): 4.
https://doi.org/10.1167/iovs.64.6.4
12. Voigt AP, Mulfaul K, Mullin NK, Flamme-Wiese MJ, Giacalone JC, Stone EM, et al. Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration. Proc Natl Acad Sci U S A 2019; 116(48): 24100-24107. https://doi.org/10.1073/pnas.1914143116
13. Geraci G, Maria Zammuto M, Vadalà M, Mattina A, Castellucci M, Guarrasi G, et al. Choroidal thickness is associated with renal hemodynamics in essential hypertension. J Clin Hypertens 2020; 22(2): 245-253.
https://doi.org/10.1111/jch.13777
14. Wu F, Zhao Y, Zhang H. Ocular Autonomic Nervous System: An Update from Anatomy to Physiological Functions. Vision 2022; 6(1): 6. https://doi.org/10.3390/vision6010006
15. Cheung CY, Biousse V, Keane PA, Schiffrin EL, Wong TY. Hypertensive eye disease. Nat Rev Dis Primers. 2022; 8(1): 14. https://doi.org/10.1038/s41572-022-00342-0
16. Di Marco E, Aiello F, Lombardo M, Di Marino M, Missiroli F, Mancino R, et al. A literature review of hypertensive retinopathy: systemic correlations and new technologies. Eur Rev Med Pharmacol Sci 2022; 26(18): 6424-6443.
https://doi.org/10.26355/eurrev_202209_29742
17. Bhayana AA, Kumar V, Tayade A, Chandra M, Chandra P, Kumar A. Choroidal thickness in normal Indian eyes using swept-source optical coherence tomography. Indian J Ophthalmol 2019; 67(2): 252-255.
https://doi.org/10.4103/ijo.IJO_668_18
18. Aşıkgarip N, Temel E, Kıvrak A, Örnek K. Choroidal structural changes and choroidal vascularity index in patients with systemic hypertension. Eur J Ophthalmol 2022; 32(4): 2427-2432. https://doi.org/10.1177/11206721211035615
19. Waghamare SR, Mittal S, Pathania M, Samanta R, Kumawat D, Gupta N, et al. Comparison of choroidal thickness in systemic hypertensive subjects with healthy individuals by spectral domain optical coherence tomography. Indian J Ophthalmol 2021; 69(5): 1183-1188. https://doi.org/10.4103/ijo.ijo_1994_20
20. Simsek EE, Kanar HS, Kanar BG, Cetin H, Arsan A, Tigen MK et al. Can ocular OCT findings be as a predictor for end-organ damage in systemic hypertension? Clin Exp Hypertens 2020; 42(8): 733-737. https://doi.org/10.1080/10641963.2020.1783548
21. Turan-Vural E, Vural U. Evaluation of Peripapillary and Subfoveal Choroid Thickness in Asymptomatic Carotid Artery Stenosis. Clin Ophthalmol 2020; 14: 1641-1650.
https://doi.org/10.2147/opth.s237403
22. Druckenbrod RC, Asefzadeh B, Bertolet A. Impact of Cardiovascular Disease Risk Factors on Subfoveal Choroidal Thickness by Enhanced-depth Spectral Domain Optical Coherence Tomography. Optom Vis Sci 2020; 97(2): 73-80. https://doi.org/10.1097/opx.0000000000001470
23. Seo WW, Yoo HS, Kim YD, Park SP, Kim YK. Choroidal vascularity index of patients with coronary artery disease. Sci Rep 2022; 12(1): 3036.
https://doi.org/10.1038/s41598-022-07120-8
24. An Y, Park SP, Kim YK. Aqueous humor inflammatory cytokine levels and choroidal thickness in patients with macular edema associated with branch retinal vein occlusion. Int Ophthalmol 2021; 41(7): 2433-2444.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Fawad Ahmad Khan, Zulfiqar Uddin Syed, Taimoor Ashraf Khan, Usman Tariq, Muhammad Jahanzaib, Muhammad Saad Naseer

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.





